1. Which of the following does NOT represent a reason for using high concentration insulin formulations in the treatment of type 2 diabetes?

2. A 55 year old female, high school teacher with Type 2 diabetes is referred to you for dosing of U500 insulin. Her current meds are NPH 100 units twice daily, lispro 10-30 units with meals plus correction, and metformin 1000mg daily. Her A1C is 7.1% and Scr is 1.1. How would you instruct the patient to draw up 110 units of U500 insulin?

3. Which of the following is NOT a strategy to overcome the barriers to insulin therapy?

4. Which of the following statements is INCORRECT regarding the new basal insulin U300 glargine?

« Return to Activity